Positive on Cadila Health, Torrent Pharma within the pharma space: Kunj Bansal, Sanlam India

In a chat with ET Now, Kunj Bansal, Chief Investment Officer, Sanlam India, shares his views on pharma space.

ET Now: How are you approaching the pharma space though there are stocks which have already seen a fair amount of run up like Dr. Reddy, Sun Pharma and then there are some new stories like Ranbaxy because of which they are getting beaten down?

Kunj Bansal: We do have an existing position in the pharma space. Also, we are adding some of the new ideas that have emerged over the last few days. I like Cadila Healthcare based on the announcement of new molecule and the decent combination between valuation and fundamentals of the company.

Sun Pharma is of course a good company, giving very good numbers. But the valuation may not be comfortable. No doubt it is a momentum investing kind of a stock and Sun Pharma could still give return. Another stock is Torrent Pharmaceuticals which is looking good and has given very good quarterly results as well.